Personal treatment of cancer, which matches a patient through a simple blood test, is welcomed as a “savior of life”, after a preliminary study.
The targeted national experience, which is taking place at Christie Hospital in Manchester, analyzes the patient’s DNA to determine the type of treatment that will work better for them.
If it succeeds, the researchers hope that the procedure will become “routinely available on NHS”.
Dr. Matthew Krebis, the chief researcher in the study, told Sky News that her research makes “precise medicine” easier for a wide range of cancer patients.
He explains: “There are small parts of the DNA that start from cancer that revolve around in the bloodstream, so that we can extract the DNA that specifically comes from cancer.”
Then this DNA is analyzed, allowing doctors to see its specific mutations and suggests a detailed treatment.
This means “instead of just dealing with medications of the type of chemotherapy” the patient gets a “more specialized” treatment.
Although the heredity and DNA test for cancer patients are already conducted in hospitals, the sample is usually collected using a biopsy.
Which can be involved in surgery, interventional, painful and – in some cases – delayed.
Read more from Kateerina Vittozzi:
The teacher stabbed
Sky News joins the slavery raid in Abattoir
Why did the wife stay with a husband after she found pictures of child abuse?
The patient’s DNA experience decomposes to determine the type of treatment that will work better for them
“It was a savior of life.”
The targeted national study, funded by the Christie Charity Foundation and the Sir Bobby Robson Foundation, hopes to employ 6000 patients, to study whether the blood test method, in fact, is a “liquid biopsy”, improves the results of the patient.
Dr. Krebis says they know that the blood test path “will not succeed for everyone”, but in some cases, enabled patients with advanced cancer with drug experiments.
Pamela Garner Jones, 78, told cervical cancer in the fourth stage “not operating” and “no longer responds to treatment.”
“They were talking about tilted care,” she said to Sky News. “I thought they were making it, I couldn’t believe it.”
At that point, the MS Garner-Jones was presented as a place in the targeted national study. Her blood test matches her with a new immunotherapy experience, which she saw that her tumor was shrinking two -thirds.
Pamela Garner Jones told the cervical cancer that was “unspeakable”, but the experimental blood test helped her reach a new drug, reduced its tumor.
“Frankly, I couldn’t ask anything more,” she says. “I have more energy, my appetite appeared – it was a savior of life.”
“It is just a simple blood test and is not completely pumped from any end of the medications.”
Ms. Garner Jones says she is now looking into a vacation with friends, meals and the ability to spend time in her garden.
“I am a factory,” she says. “Like a dog with two tails!”